000 03276nam a22003855i 4500
001 86019
003 ES-MaUEC
005 20230207040538.0
007 cr nn 008mamaa
008 160727s2016 gw | s |||| 0|eng d
020 _a9783319335551
040 _aES-MaUEC
050 4 _aRC394.D35
_bM346 2016
082 0 4 _a612.8
245 1 0 _aMagnetic Resonance Spectroscopy of Degenerative Brain Diseases
_cedited by Gülin Öz
260 _aCham
_bSpringer International Publishing
_c2016
300 _a1 recurso en línea (XV, 268 páginas)
_b55 ilustraciones, 32 ilustraciones en color
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 0 _aContemporary Clinical Neuroscience
505 0 _aImaging Neurodegeneration: What can Magnetic Resonance Spectroscopy Contribute? -- Methodology of MRS in animal models: Technical challenges and solutions -- Methodology of clinical MRS: Technical challenges and solutions -- Magnetic Resonance Spectroscopy in Dementia -- Magnetic Resonance Spectroscopy in Parkinsonian Disorders -- Magnetic Resonance Spectroscopy in Huntington�s Disease -- Magnetic Resonance Spectroscopy in Motor Neuron Diseases -- Magnetic Resonance Spectroscopy in Multiple Sclerosis -- Magnetic Resonance Spectroscopy in Ataxias -- Magnetic Resonance Spectroscopy in Prion Diseases -- Magnetic Resonance Spectroscopy in HIV-Associated Neurocognitive Disorders (HAND) -- Magnetic Resonance Spectroscopy in Epilepsy.
520 3 _aThe proposed book will act as a guide for scientists and clinicians to the unique information that MRS can provide. It will be a comprehensive overview of clinical and pre-clinical MRS applications and potential clinical utility of MRS biomarkers in degenerative brain diseases from leading experts in the field. MRS has proven to be a powerful complementary tool to MRI for the diagnosis and monitoring of disease progression and response to treatment because it can detect changes in cell density, cell type, and biochemical composition, not just structural changes. As the population in the developed world continues to age, neuroimaging for diagnosis, prognosis, and therapy monitoring of neurodegenerative diseases becomes increasingly important and there has been a recent surge of clinical and pre-clinical applications of MRS indicating that this technique can provide robust and non-invasive biomarkers of degeneration.
710 2 _aSpringerLink (Online service)
_0Local
_9106996
942 _2lcc
_cLE
988 _aEBOOK, asignarmaterias , EBSPRINGER
650 7 _aMedicina
_0comprobar BNE19900959047
_2embne
_9405021
650 7 _aNeurociencias
_0comprobar BNE20012490612
_2embne
_9158907
700 1 _aÖz, Gülin.
_eeditor literario
_999409
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-33555-1
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901 _ai9783319335551
907 _a.b12952977
_b10-10-17
_c21-11-16
998 _am
_a_alco
_a_vill
_b - -
_cm
_dz
_e-
_feng
_ggw
_h0
945 _aRC394.D35 M346 2016 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11595590
_z06-04-17
999 _c86019
_d86019
_x1